How he works
Dr Harinarayanan treats bowel cancer, and cancer that has spread to a small number of places, using radiotherapy, chemotherapy and immunotherapy. He plans the treatment, oversees it and sees you throughout. Most of his patients come through a surgeon, another oncologist or a multidisciplinary team (an MDT, the meeting where specialists review a case together), and he is a core member of the regional bowel cancer MDT at Southampton.
His approach is precision: giving the highest useful dose to the cancer and the lowest possible dose to everything around it. That is what MR-Linac SABR is for, and it is why he trained for it.
Training
- Medical training at Saint Petersburg State Medical Academy, then hospitals in London and the West Midlands.
- Specialist oncology training across Wessex and London.
- Postgraduate qualification in oncology from the Institute of Cancer Research, London.
- Proton therapy clinical education at the University of Pennsylvania.
- MR-Linac SABR accreditation from GenesisCare UK.
Research
He was principal investigator for APHRODITE, a completed national trial of organ-preserving radiotherapy in rectal cancer, which looked at whether suitable patients can keep their bowel and avoid a permanent stoma.
Roles and memberships
- Consultant Clinical Oncologist, University Hospital Southampton NHS Foundation Trust.
- Core member, regional lower gastrointestinal (bowel) multidisciplinary team.
- Elected staff governor for medical and dental staff, University Hospital Southampton.
- Member, British Association Colorectal Oncology Group.
Registration
Registered with the General Medical Council, number 6083771. Recognised by Aetna, Aviva, AXA PPP, Bupa, Cigna, Healix, Vitality, WPA. Self-pay patients are welcome.